CHICAGO, July 31, 2012 /PRNewswire/ -- The one-time poster child of birth control prescriptions, Yaz (and Yasmin) has quickly become one of the riskiest oral contraceptives available.
Released in 2006, the contraceptive Yaz generated sales of nearly $2 billion in its first year alone, making it the one time leading birth control pill on the market and Bayer HealthCare Pharmaceutical's top-selling drug.
But in 2012, Bayer is facing over 15,000 lawsuits involving this same blockbuster drug.
Promoted as the choice for women seeking relief from premenstrual symptoms and acne, Yaz's marketing touted the birth control pill as one with multiple benefits. "Yaz is the only birth control pill proven to treat the physical and emotional premenstrual symptoms that are severe enough to impact your life," claimed many of the advertisements; advertising statements that have since been removed.
Instead, recent studies have shown that this marketing was not only misleading but also dangerous. These independent studies have found that Yaz carries higher blood clotting risks than other leading birth control pills.
The attorneys at TorHoerman Law are actively representing women affected by the life-altering side effects of Yaz and Yasmin. The most common injuries involve women who have suffered stroke, Deep Vein Thrombosis (DVT) or Pulmonary Embolism after taking Yaz or Yasmin.
In their second quarter financial statements, Bayer announced that agreements had been reached to settle the claims of 1,877 claimants in the U.S. for a total amount of about $402.6 million. These numbers increased since the first quarter, when Bayer announced they had settled the claims of 651 plaintiffs in the U.S. for a total amount of about $142 million.
TorHoerman Law urges any women that experienced any of these side effects to contact an experienced attorney soon to investigate whether you have a right to compensation for your injuries. http://www.torhoermanlaw.com
|SOURCE TorHoerman Law|
Copyright©2012 PR Newswire.
All rights reserved